{
  "authors": [
    {
      "author": "Patrick W Fisher"
    },
    {
      "author": "L Tammy Ho"
    },
    {
      "author": "Robert Goldschmidt"
    },
    {
      "author": "Ronald J Semerdjian"
    },
    {
      "author": "Gregory W Rutecki"
    }
  ],
  "doi": "10.1186/1471-2369-4-6",
  "publication_date": "2003-08-12",
  "id": "EN119785",
  "url": "https://pubmed.ncbi.nlm.nih.gov/12908875",
  "source": "BMC nephrology",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We report an individual heterozygous for the M680I gene mutation with a clinical diagnosis of FMF using the Tel-Hashomer criteria. Subsequently, the patient developed nephrotic syndrome with biopsy-confirmed fibrillary glomerulonephritis (FGN). Further diagnostic studies were unremarkable with clinical workup negative for amyloidosis or other secondary causes of nephrotic syndrome."
}